Rajini Nagarajah
- Molecular Biology
- Cancer Research top 5%
- Biochemistry top 5%
- Oncology
- Cellular and Molecular Neuroscience
- Co-authors
- John E.J. RaskoJeff HolstMichelle van GeldermalsenAnnora ThoengDadi GaoQian WangWilliam RitchieAmy D. Marshall
- Topics
- Neuroscience and Neuropharmacology Research (5 papers)RNA modifications and cancer (5 papers)RNA Research and Splicing (5 papers)
- Cited by
- Cancer ResearchBiochemistryNeurology
- Journals
- CellNature CommunicationsOncogene
- Partner nations
- AustraliaSingaporeUnited States
In The Last Decade
Rajini Nagarajah
20 papers receiving 893 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Molecular Biology 582
- Cancer Research 382
- Biochemistry 168
- Oncology 112
- Cellular and Molecular Neuroscience 108
Countries citing papers authored by Rajini Nagarajah
This map shows the geographic impact of Rajini Nagarajah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajini Nagarajah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajini Nagarajah more than expected).
Fields of papers citing papers by Rajini Nagarajah
This network shows the impact of papers produced by Rajini Nagarajah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajini Nagarajah. The network helps show where Rajini Nagarajah may publish in the future.
Co-authorship network of co-authors of Rajini Nagarajah
This figure shows the co-authorship network connecting the top 25 collaborators of Rajini Nagarajah. A scholar is included among the top collaborators of Rajini Nagarajah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajini Nagarajah. Rajini Nagarajah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 7 | |
| 7 | 12 | |
| 8 | 27 | |
| 9 | 11 | |
| 10 | 16 | |
| 11 | 76 | |
| 12 | 63 | |
| 13 | 16 | |
| 14 | ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancerbreakdown → | 478 |
| 15 | 7 | |
| 16 | 9 | |
| 17 | 29 | |
| 18 | 98 | |
| 19 | 12 | |
| 20 | 31 |
About Rajini Nagarajah
Rajini Nagarajah is a scholar working on Neurology, Biochemistry and Biological Psychiatry, having authored 20 papers that have together received 901 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (382 citations), Biochemistry (168 citations) and Neurology (97 citations). Rajini Nagarajah has collaborated with scholars based in Australia, Singapore and United States. Frequent co-authors include John E.J. Rasko, Jeff Holst, Michelle van Geldermalsen, Annora Thoeng, Dadi Gao, Qian Wang, William Ritchie, Amy D. Marshall, Charles G. Bailey and Guo Jun Liu. Their work appears in journals such as Cell, Nature Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.